Of note, a particularly high prevalence of FGF amplifications can be found in HNSCC, particularly affecting FGF3 (22.9%), FGF4 (21.2%), and FGF19 (22.6%) [24]. The gene discussed is FGF4; the disease is head and neck squamous cell carcinoma.